CIK 2092021
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 93.05% | 105 |
| Unclassified | 6.73% | 8 |
| Health Care Providers & Services | 0.22% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | CGON | CG Oncology, Inc. | Health Care | 30.92% |
| 2 | TNGX | Tango Therapeutics, Inc. | Health Care | 3.33% |
| 3 | RVMD | Revolution Medicines, Inc. | Health Care | 2.49% |
| 4 | TYRA | Tyra Biosciences, Inc. | Health Care | 2.38% |
| 5 | LQDA | Liquidia Corp | Health Care | 2.25% |
| 6 | AGIO | AGIOS PHARMACEUTICALS, INC. | Health Care | 2.25% |
| 7 | IPSC | Century Therapeutics, Inc. | Health Care | 2.11% |
| 8 | ELVN | Enliven Therapeutics, Inc. | Health Care | 2.04% |
| 9 | PCVX | Vaxcyte, Inc. | Health Care | 2.00% |
| 10 | TNGX | Tango Therapeutics, Inc. | Health Care | 2.00% |
106/114 names classified · sector 93.3% of weight · industry 93.3% · mkt cap 90.4%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 93.3% of the book is sector-classified (unclassified names shown, never dropped).
Only 1% of book weight classified — the grid is NOT representative of the whole book.
Classified: 1.1% of book weight (5/98 names) · unclassified 98.9%: CGON, TNGX, , ELVN, PHVS, AVTX, RVMD, LQDA, TYRA, PCVX +83 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | CGONCG ONCOLOGY INC | 1,439,393 | $97M | 30.9% | NEW |
| 2 | TNGXTANGO THERAPEUTICS INC | 502,012 | $11M | 3.3% | ADD 133% |
| 3 | RVMDREVOLUTION MEDICINES INC | 80,792 | $8M | 2.5% | ADD 23% |
| 4 | TYRATYRA BIOSCIENCES INC | 195,685 | $7M | 2.4% | ADD 146% |
| 5 | LQDALIQUIDIA CORPORATION | 187,876 | $7M | 2.3% | ADD 106% |
| 6 | AGIOAGIOS PHARMACEUTICALS INC | 209,547 | $7M | 2.2% | ADD 560% |
| 7 | IPSCCENTURY THERAPEUTICS INC | 2,947,826 | $7M | 2.1% | NEW |
| 8 | ELVNENLIVEN THERAPEUTICS INC | 164,030 | $6M | 2.0% | ADD 64% |
| 9 | PCVXVAXCYTE INC | 108,450 | $6M | 2.0% | ADD 328% |
| 10 | TNGXTANGO THERAPEUTICS INC | 300,648 | $6M | 2.0% | NEW |
| 11 | COGTCOGENT BIOSCIENCES INC | 149,399 | $6M | 1.8% | TRIM −30% |
| 12 | AVTXAVALO THERAPEUTICS INC | 360,064 | $5M | 1.7% | NEW |
| 13 | NERVMINERVA NEUROSCIENCES INC | 889,254 | $5M | 1.7% | NEW |
| 14 | CGONCG ONCOLOGY INC | 75,758 | $5M | 1.6% | TRIM −95% |
| 15 | PHVSPHARVARIS N V | 172,731 | $5M | 1.5% | ADD 212% |
| 16 | ABVXABIVAX SA | 43,052 | $5M | 1.5% | ADD 219% |
| 17 | DNTHDIANTHUS THERAPEUTICS INC | 54,258 | $5M | 1.4% | ADD 270% |
| 18 | PHVSPHARVARIS N V | 143,966 | $4M | 1.3% | NEW |
| 19 | CYTKCYTOKINETICS INC | 61,269 | $4M | 1.3% | ADD 493% |
| 20 | SOLENO THERAPEUTICS INC | 115,770 | $4M | 1.2% | TRIM −11% |
| 21 | ELVNENLIVEN THERAPEUTICS INC | 95,253 | $4M | 1.2% | NEW |
| 22 | ERASERASCA INC | 222,468 | $4M | 1.1% | NEW |
| 23 | ROIVROIVANT SCIENCES LTD | 128,168 | $4M | 1.1% | NEW |
| 24 | CTMXCYTOMX THERAPEUTICS INC. | 714,000 | $3M | 1.1% | NEW |
| 25 | AVTXAVALO THERAPEUTICS INC | 213,819 | $3M | 1.0% | ADD 238% |
| 26 | EPRXEupraxia Pharmaceuticals Inc | 433,515 | $3M | 1.0% | NEW |
| 27 | IDYAIDEAYA BIOSCIENCES INC | 86,283 | $3M | 0.9% | NEW |
| 28 | TSHATAYSHA GENE THERAPIES INC | 625,708 | $3M | 0.9% | ADD 274% |
| 29 | ASNDASCENDIS PHARMA A/S | 12,179 | $3M | 0.9% | ADD 115% |
| 30 | CMPXCOMPASS THERAPEUTICS INC | 516,972 | $3M | 0.9% | TRIM −9% |
| 31 | DMRADAMORA THERAPEUTICS INC | 101,248 | $3M | 0.8% | NEW |
| 32 | KALVISTA PHARMACEUTICALS INC | 128,487 | $3M | 0.8% | ADD 165% |
| 33 | RLAYRELAY THERAPEUTICS INC | 257,738 | $3M | 0.8% | ADD 253% |
| 34 | AXSMAXSOME THERAPEUTICS INC. | 14,055 | $2M | 0.8% | ADD 8% |
| 35 | CMPXCOMPASS THERAPEUTICS INC | 423,566 | $2M | 0.7% | NEW |
| 36 | DIANTHUS THERAPEUTICS INC | 26,551 | $2M | 0.7% | NEW |
| 37 | EPRXEUPRAXIA PHARMACEUTICALS INC | 276,000 | $2M | 0.6% | NEW |
| 38 | DFTXDEFINIUM THERAPEUTICS INC COM SHS | 99,887 | $2M | 0.6% | NEW |
| 39 | MLYSMINERALYS THERAPEUTICS INC | 69,571 | $2M | 0.6% | ADD 66% |
| 40 | SOLENO THERAPEUTICS INC | 54,000 | $2M | 0.6% | NEW |
| 41 | MDGLMADRIGAL PHARMACEUTICALS INC | 3,393 | $2M | 0.6% | ADD 82% |
| 42 | CTMXCYTOMX THERAPEUTICS INC. | 371,398 | $2M | 0.6% | ADD 660% |
| 43 | LONALEONABIO INC | 164,676 | $2M | 0.5% | ADD 29% |
| 44 | SVRASAVARA INC | 295,688 | $2M | 0.5% | ADD 371% |
| 45 | CATXPERSPECTIVE THERAPEUTICS INC | 379,082 | $2M | 0.5% | NEW |
| 46 | ASMBASSEMBLY BIOSCIENCES INC | 56,147 | $2M | 0.5% | TRIM −24% |
| 47 | SAB BIOTHERAPEUTICS INC | 400,000 | $2M | 0.5% | NEW |
| 48 | NERVMINERVA NEUROSCIENCES INC | 248,476 | $1M | 0.5% | NEW |
| 49 | ZLABZAI LAB LTD | 77,858 | $1M | 0.5% | NEW |
| 50 | TARSTARSUS PHARMACEUTICALS INC | 19,800 | $1M | 0.4% | ADD 340% |
| 51 | CRVSCORVUS PHARMACEUTICALS INC | 82,890 | $1M | 0.4% | NEW |
| 52 | PCVXVAXCYTE INC | 20,000 | $1M | 0.4% | NEW |
| 53 | AVBPARRIVENT BIOPHARMA INC | 50,252 | $1M | 0.4% | NEW |
| 54 | LRMRLARIMAR THERAPEUTICS INC | 256,585 | $1M | 0.4% | NEW |
| 55 | KRYSKRYSTAL BIOTECH INC | 4,316 | $1M | 0.4% | ADD 8% |
| 56 | IVAINVENTIVA SA | 200,141 | $1M | 0.4% | NEW |
| 57 | LPCNLIPOCINE INC NEW | 124,942 | $998,287 | 0.3% | NEW |
| 58 | SYRESPYRE THERAPEUTICS INC | 19,690 | $993,164 | 0.3% | NEW |
| 59 | BCRXBIOCRYST PHARMACEUTICALS INC | 102,493 | $975,733 | 0.3% | NEW |
| 60 | XNCRXENCOR INC | 80,000 | $964,800 | 0.3% | TRIM −27% |
| 61 | CLDXCELLDEX THERAPEUTICS INC NEW | 29,300 | $929,396 | 0.3% | NEW |
| 62 | REPLREPLIMUNE GROUP INC | 120,400 | $921,060 | 0.3% | NEW |
| 63 | MAZEMAZE THERAPEUTICS INC | 30,707 | $916,604 | 0.3% | NEW |
| 64 | CLYMCLIMB BIO INC | 130,654 | $894,980 | 0.3% | ADD 71% |
| 65 | CMPSCOMPASS PATHWAYS PLC | 158,021 | $873,856 | 0.3% | ADD 295% |
| 66 | ALKSALKERMES PLC | 24,170 | $854,651 | 0.3% | NEW |
| 67 | SLNSILENCE THERAPEUTICS PLC | 156,759 | $826,120 | 0.3% | ADD 6% |
| 68 | CRBPCORBUS PHARMACEUTICALS HLDGS | 85,687 | $804,601 | 0.3% | ADD 51% |
| 69 | CELCCELCUITY INC | 6,000 | $684,840 | 0.2% | TRIM −28% |
| 70 | ANTXAN2 THERAPEUTICS INC | 199,701 | $682,977 | 0.2% | NEW |
| 71 | DNLIDENALI THERAPEUTICS INC | 35,286 | $677,491 | 0.2% | NEW |
| 72 | UTHRUnited Therapeutics Corp. | 1,128 | $668,881 | 0.2% | TRIM −13% |
| 73 | LLYELI LILLY & CO | 720 | $662,234 | 0.2% | NEW |
| 74 | VSTMVERASTEM INC | 123,400 | $654,020 | 0.2% | ADD 715% |
| 75 | LQDALIQUIDIA CORPORATION | 17,000 | $641,580 | 0.2% | NEW |
| 76 | GERNGERON CORP | 424,180 | $632,028 | 0.2% | TRIM −45% |
| 77 | IRDOPUS GENETICS INC | 134,242 | $610,801 | 0.2% | NEW |
| 78 | IKTINHIBIKASE THERAPEUTICS INC | 325,600 | $547,008 | 0.2% | TRIM −39% |
| 79 | CNTXCONTEXT THERAPEUTICS INC | 190,785 | $499,857 | 0.2% | NEW |
| 80 | DRUGBRIGHT MINDS BIOSCIENCES INC | 6,395 | $466,644 | 0.1% | NEW |
| 81 | VYGRVOYAGER THERAPEUTICS INC | 115,203 | $444,684 | 0.1% | NEW |
| 82 | GPCRSTRUCTURE THERAPEUTICS INC | 9,000 | $433,800 | 0.1% | NEW |
| 83 | PTGXPROTAGONIST THERAPEUTICS INC | 4,000 | $421,600 | 0.1% | TRIM −50% |
| 84 | PRTAPROTHENA CORP PLC | 43,300 | $420,876 | 0.1% | HOLD |
| 85 | NTLAINTELLIA THERAPEUTICS INC | 31,500 | $403,830 | 0.1% | NEW |
| 86 | MISTMILESTONE PHARMACEUTICALS IN | 333,333 | $396,666 | 0.1% | NEW |
| 87 | SABSSAB BIOTHERAPEUTICS INC | 100,000 | $383,000 | 0.1% | NEW |
| 88 | PALIPALISADE BIO INC | 213,100 | $372,925 | 0.1% | TRIM −35% |
| 89 | GLUEMONTE ROSA THERAPEUTICS INC | 22,530 | $370,619 | 0.1% | ADD 463% |
| 90 | EWTXEDGEWISE THERAPEUTICS INC | 11,701 | $368,582 | 0.1% | ADD 485% |
| 91 | UNCYUNICYCIVE THERAPEUTICS INC | 55,700 | $366,506 | 0.1% | NEW |
| 92 | CTNMCONTINEUM THERAPEUTICS INC | 27,054 | $353,325 | 0.1% | NEW |
| 93 | TRVITREVI THERAPEUTICS INC | 27,149 | $323,887 | 0.1% | ADD 282% |
| 94 | EOLSEVOLUS INC | 78,057 | $320,814 | 0.1% | TRIM −5% |
| 95 | NKTRNEKTAR THERAPEUTICS | 4,300 | $309,385 | 0.1% | TRIM −71% |
| 96 | FULCFULCRUM THERAPEUTICS INC | 38,100 | $292,227 | 0.1% | NEW |
| 97 | SEPNSEPTERNA INC | 11,445 | $275,023 | 0.1% | HOLD |
| 98 | OCULOCULAR THERAPEUTIX INC | 31,296 | $265,077 | 0.1% | ADD 83% |
| 99 | ZNTLZENTALIS PHARMACEUTICALS INC | 110,000 | $257,400 | 0.1% | NEW |
| 100 | AMLXAMYLYX PHARMACEUTICALS INC | 16,671 | $231,727 | 0.1% | ADD 44% |
| 101 | ENTXENTERA BIO LTD | 205,542 | $228,152 | 0.1% | ADD 52% |
| 102 | NUVLNUVALENT INC | 2,072 | $212,276 | 0.1% | TRIM −84% |
| 103 | BEAMBEAM THERAPEUTICS INC | 8,804 | $209,800 | 0.1% | TRIM −8% |
| 104 | IRONDISC MEDICINE INC | 3,231 | $206,590 | 0.1% | NEW |
| 105 | WHWKWHITEHAWK THERAPEUTICS INC | 54,296 | $187,321 | 0.1% | NEW |
| 106 | INBXINHIBRX BIOSCIENCES INC | 2,482 | $166,865 | 0.1% | NEW |
| 107 | APGEAPOGEE THERAPEUTICS INC | 1,969 | $165,731 | 0.1% | ADD 9% |
| 108 | CCCCC4 THERAPEUTICS INC | 57,076 | $150,110 | 0.0% | NEW |
| 109 | PMNPROMIS NEUROSCIENCES INC | 10,600 | $134,620 | 0.0% | NEW |
| 110 | TYRATYRA BIOSCIENCES INC | 2,900 | $111,070 | 0.0% | NEW |
| 111 | PEPGPEPGEN INC | 59,500 | $105,315 | 0.0% | NEW |
| 112 | PMVPPMV PHARMACEUTICALS INC | 63,498 | $78,738 | 0.0% | HOLD |
| 113 | MGNXMACROGENICS INC | 13,387 | $38,688 | 0.0% | NEW |
| 114 | CGEMCULLINAN THERAPEUTICS INC | 1,844 | $26,203 | 0.0% | TRIM −39% |
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| CGONCG ONCOLOGY INC | — | — | — | — | — | 1.4M | $97M |
| TNGXTANGO THERAPEUTICS INC | — | — | — | — | 215K | 502K | $11M |
| RVMDREVOLUTION MEDICINES INC | — | — | — | — | 66K | 81K | $8M |
| TYRATYRA BIOSCIENCES INC | — | — | — | — | 80K | 196K | $7M |
| LQDALIQUIDIA CORPORATION | — | — | — | — | 91K | 188K | $7M |
| AGIOAGIOS PHARMACEUTICALS INC | — | — | — | — | 32K | 210K | $7M |
| IPSCCENTURY THERAPEUTICS INC | — | — | — | — | — | 2.9M | $7M |
| ELVNENLIVEN THERAPEUTICS INC | — | — | — | — | 100K | 164K | $6M |
| PCVXVAXCYTE INC | — | — | — | — | 25K | 108K | $6M |
| TNGXTANGO THERAPEUTICS INC | — | — | — | — | — | 301K | $6M |
| COGTCOGENT BIOSCIENCES INC | — | — | — | — | 214K | 149K | $6M |
| AVTXAVALO THERAPEUTICS INC | — | — | — | — | — | 360K | $5M |
| NERVMINERVA NEUROSCIENCES INC | — | — | — | — | — | 889K | $5M |
| CGONCG ONCOLOGY INC | — | — | — | — | 1.5M | 76K | $5M |
| PHVSPHARVARIS N V | — | — | — | — | 55K | 173K | $5M |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
Where this firm's principals came from and which firms its alumni went on to found.
